Ancylostoma ceylanicum anticoagulant peptide-1: Role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa

Molecular and Biochemical Parasitology

Volumn 137, Issue 1, 2004, Pages 151-159

  Mieszczanek, Juliusz ^a,b   Harrison, Lisa M ^a   Cappello, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

IPTG; isopropyl D thiogalactopyranoside; kDa; kilodaltons; molecular weight; MW; PCR; polymerase chain reaction; reverse phase high pressure liquid chromatography; rpHPLC; SDS PAGE; sodium dodecyl sulfate polyacrylamide gel electrophoresis; TFA

Indexed keywords

AMINO ACID; ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANCYLOSTOMA CEYLANICUM; ARTICLE; DRUG BINDING SITE; ENZYME ACTIVE SITE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REACTIVE INHIBITION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANCYLOSTOMA; ANIMALS; BINDING SITES; BLOOD COAGULATION; FACTOR V; FACTOR VIIA; FACTOR XA; HELMINTH PROTEINS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS;

ANCYLOSTOMA; ANCYLOSTOMA CANINUM; ANCYLOSTOMA CEYLANICUM; ANCYLOSTOMATOIDEA; MAMMALIA;

EID: 3342988385     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2004.05.011     Document Type: Article

References (56)

1. Stoltzfus R.J., Chwaya H.M., Tielsch J.M., Schulze K.J., Albonico M., Savioli L. Epidemiology of iron deficiency anemia in Zanzibari schoolchildren: the importance of hookworms. Am J Clin Nutr. 65:1997;153-159
2. Crompton DWT. The public health importance of hookworm. J Parasitol 2000;121:S39-50.
3. de Silva N.R., Brooker S., Hotez P.J., Montresor A., Engels D., Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19:2003;547-551
4. Cappello M., Harrison L.M., Bungiro J.R.D., et al. The molecular pathogenesis of hookworm anemia: prospects for a disease based vaccine. J Parasitol. 89:2003;158-164
5. Kalkofen U.P. Attachment and feeding behavior of Ancylostoma caninum. Z Parasitenkd. 33:1970;339-354
6. Loeb L., Fleisher M.S. The influence of extracts of Anchylostoma caninum on the coagulation of the blood and on hemolysis. J Infect Dis. 7:1910;625-631
7. Spellman G.G. Jr., Nossel H.L. Anticoagulant activity of dog hookworm. Am J Physiol. 220:1971;922-927
8. Stassens P., Bergum P.W., Gansemans Y., et al. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA. 93:1996;2149-2154
9. Cappello M., Vlasuk G.P., Bergum P.W., Huang S., Hotez P.J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA. 92:1995;6152-6156
10. Carroll S.M., Howse D.J., Grove D.I. The anticoagulant effects of the hookworm, Ancylostoma ceylanicum: observations on human and dog blood in vitro and infected dogs in vivo. Thromb Haemost. 51:1984;222-227
11. Thorson R.E. The effect of extracts of the amphidial glands, excretory glands, and esophagus of adults of Ancylostoma caninum on the coagulation of dog's blood. J Parasitol. 42:1956;26-30
12. Eiff J.A. Nature of an anticoagulant from the cephalic glands of Ancylostoma caninum. J Parasitol. 52:1966;833-843
13. Harrison L.M., Nerlinger A., Bungiro R.D., Cordova J.L., Kuzmic P., Cappello M. Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. J Biol Chem. 277:2002;6223-6229
14. Cappello M., Clyne L.P., McPhedran P., Hotez P.J. Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J Infect Dis. 167:1993;1474-1477
15. Grasberger B.L., Clore G.M., Gronenborn A.M. High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Structure. 2:1994;669-678
16. Bernard V.D., Peanasky R.J. The serine protease inhibitor family from Ascaris suum: chemical determination of the five disulfide bridges. Arch Biochem Biophys. 303:1993;367-376
17. Homandberg G.A., Litwiller R.D., Peanasky R.J. Carboxypeptidase inhibitors from Ascaris suum: the primary structure. Arch Biochem Biophys. 270:1989;153-161
18. Martzen M.R., Peanasky R.J. Ascaris suum: biosynthesis and isoinhibitor profile of chymotrypsin/elastase isoinhibitors. Exp Parasitol. 59:1985;313-320
19. Goodman R.B., Peanasky R.J. Isolation of the trypsin inhibitors in Ascaris lumbricoides var. suum using affinity chromatography. Anal Biochem. 120:1982;387-393
20. Cappello M., Hawdon J.M., Jones B.F., Kennedy W.P., Hotez P.J. Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli. Mol Biochem Parasitol. 80:1996;113-137
21. Bergum P.W., Cruikshank A., Maki S.L., Kelly C.R., Ruf W., Vlasuk G.P. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J Biol Chem. 276:2001;10063-10071
22. Buddai S.K., Toulokhonova L., Bergum P.W., Vlasuk G.P., Krishnaswamy S. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J Biol Chem. 277:2002;26689-26698
23. Moons A.H., Peters R.J., Bijsterveld N.R., et al. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. J Am Coll Cardiol. 41:2003;2147-2153
24. Lee A.Y., Vlasuk G.P. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor. J Intern Med. 254:2003;313-321
25. Vlasuk G.P., Rote W.E. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc Med. 12:2002;325-331
26. Mieszczanek J., Harrison L.M., Vlasuk G.P., Cappello M. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol Biochem Parasitol. 133:2004;319-323
27. Chowdhury A.B., Schad G.A. Ancylostoma ceylanicum: a parasite of man in Calcutta and environs. Am J Trop Med Hyg. 21:1972;300-3001
28. Yoshida Y., Okamoto K., Chiu J.K. Ancylostoma ceylanicum infection in dogs, cats, and man in Taiwan. Am J Trop Med Hyg. 17:1968;378-381
29. Milstone A.M., Harrison L.M., Bungiro R.D., Kuzmic P., Cappello M. A broad spectrum Kunitz type serine protease inhibitor secreted by the hookworm Ancylostoma ceylanicum. J Biol Chem. 275:2000;29391-29399
30. Donnelly K.M., Bromberg M.E., Milstone A., et al. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro. Thromb Haemost. 79:1998;1041-1047
31. Cappello M., Bergum P.W., Vlasuk G.P., Furmidge B.A., Pritchard D.I., Aksoy S. Isolation and characterization of the tsetse thrombin inhibitor: a potent antithrombotic peptide from the saliva of Glossina morsitans morsitans. Am J Trop Med Hyg. 54:1996;475-480
32. Laskowski M., Qasim M.A. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes? Biochim Biophys Acta. 1477:2000;324-337
33. Qasim M.A., Lu S.M., Ding J., et al. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases. Biochemistry. 38:1999;7142-7150
34. Bode W., Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta. 1477:2000;241-252
35. Helland R., Czapinska H., Leiros I., Olufsen M., Otlewski J., Smalas A.O. Structural consequences of accommodation of four non-cognate amino acid residues in the S1 pocket of bovine trypsin and chymotrypsin. J Mol Biol. 333:2003;845-861
36. Yao P.L., Hwang M.J., Chen Y.M., Yeh K.W. Site-directed mutagenesis evidence for a negatively charged trypsin inhibitory loop in sweet potato sporamin. FEBS Lett. 496:2001;134-138
37. Otlewski J., Jaskolski M., Buczek O., et al. Structure-function relationship of serine protease-protein inhibitor interaction. Acta Biochim Pol. 48:2001;419-428
38. Krowarsch D., Otlewski J. Amino-acid substitutions at the fully exposed P1 site of bovine pancreatic trypsin inhibitor affect its stability. Protein Sci. 10:2001;715-724
39. Lu W., Apostol I., Qasim M.A., et al. Binding of amino acid side-chains to S1 cavities of serine proteinases. J Mol Biol. 266:1997;441-461
40. Lu C.C., Nguyen T., Morris S., Hill D., Sakanari J.A. Anisakis simplex: mutational bursts in the reactive site centers of serine protease inhibitors from an ascarid nematode. Exp Parasitol. 89:1998;257-261
41. Goodwin R.L., Baumann H., Berger F.G. Patterns of divergence during evolution of alpha 1-proteinase inhibitors in mammals. Mol Biol Evol. 13:1996;346-358
42. Wang Z.Y., Wang X.Z., Peng Y.F., et al. Blood sucking activities of hookworms, Routes and quantities of blood loss in Ancylostoma caninum, A. duodenale and A. ceylanicum infections. Chin Med J (Engl). 96:1983;281-286
43. Rep B.H. Pathogenicity of hookworms. The significance of population regression for the pathogenicity of hookworms. Trop Geogr Med. 32:1980;251-255
44. Cappello M.H.L., Bungiro R.D., Chadderdon C.R., et al. Molecular pathogenesis of hookworm anemia: prospects for a disease based vaccine. J Parasitol. 89:2003;S158-S164
45. Chu D., Bungiro R.D., Ibanez M., et al. Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay. Infect Immun. 72:2004;2214-2221
46. Bungiro R.D. Jr., Solis C.V., Harrison L.M., Cappello M. Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms. Infect Immun. 72:2004;2203-2213
47. De Jonge E., Friederich P.W., Vlasuk G.P., et al. Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diagn Lab Immunol. 10:2003;495-497
48. Friederich P.W., Levi M., Bauer K.A., et al. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation. 103:2001;2555-2559
49. Vlasuk G.P. The new anticoagulants: new opportunities, new issues. Arch Pathol Lab Med. 122:1998;812-814
50. Bromberg M.E., Cappello M. Cancer and blood coagulation: molecular aspects. Cancer J Sci Am. 5:1999;132-138
51. Hembrough T.A., Swartz G.M., Papathanassiu A., et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res. 63:2003;2997-3000
52. Jiang X., Bailly M.A., Panetti T.S., Cappello M., Konigsberg W.H., Bromberg M.E. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J Thromb Haemost. 2:2004;93-101
53. Moons A.H., Peters R.J., Cate H., et al. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost. 88:2002;627-631
54. Houston D.S. Tissue factor - a therapeutic target for thrombotic disorders. Expert Opin Ther Targets. 6:2002;159-174
55. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Kagan E., Hensley L.E. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis. 188:2003;1618-1629
56. Geisbert T.W., Hensley L.E., Jahrling P.B., et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet. 362:2003;1953-1958